Factors associated with life satisfaction in systemic sclerosis: Examining the moderating roles of social support and spiritual well-being.
Functional limitations
scleroderma
social support
spiritual well-being
spirituality
systemic sclerosis
Journal
Journal of scleroderma and related disorders
ISSN: 2397-1991
Titre abrégé: J Scleroderma Relat Disord
Pays: England
ID NLM: 101685427
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
medline:
7
6
2023
pubmed:
7
6
2023
entrez:
7
6
2023
Statut:
ppublish
Résumé
Systemic sclerosis often has a significant impact on an individual's quality of life. Life satisfaction is a subjective expression of well-being and a key component of quality of life. We examined the associations between functional limitations, social support, and spiritual well-being with life satisfaction and investigated the moderating roles of social support and spiritual well-being on the relationship between functional limitations and life satisfaction in people with systemic sclerosis. Data were drawn from the baseline University of California Los Angeles Scleroderma Quality of Life Study. Participants completed questionnaires that included demographics, depressive symptoms, functional limitations, social support, and spiritual well-being. The Satisfaction with Life Scale was used to evaluate overall life satisfaction. Data were analyzed using a hierarchical linear regression. Of 206 participants (84% female, 74% White, 52% limited cutaneous subtype, 51% early disease), 38% reported being dissatisfied with their lives. Functional limitations (β = -0.19, Spiritual well-being is particularly important in understanding life satisfaction in people with systemic sclerosis. Future longitudinal research is needed to assess and examine spiritual well-being and its impact on life satisfaction in a larger and more diverse systemic sclerosis sample.
Identifiants
pubmed: 37283281
doi: 10.1177/23971983221146366
pmc: PMC10202482
mid: NIHMS1877047
doi:
Types de publication
Journal Article
Langues
eng
Pagination
107-112Subventions
Organisme : ACL HHS
ID : 90ARCP0003
Pays : United States
Organisme : NIAMS NIH HHS
ID : K24 AR063120
Pays : United States
Références
J Dtsch Dermatol Ges. 2016 Jul;14(7):717-28
pubmed: 27373247
Disabil Rehabil. 2020 Jun;42(11):1588-1598
pubmed: 30761932
Ann Rheum Dis. 2018 Aug;77(8):1118-1124
pubmed: 29625967
Arthritis Rheum. 2005 Apr 15;53(2):256-62
pubmed: 15818719
J Pers Assess. 1985 Feb;49(1):71-5
pubmed: 16367493
Rheumatology (Oxford). 2021 Oct 2;60(10):4717-4727
pubmed: 33521812
Support Care Cancer. 2011 Jun;19(6):757-64
pubmed: 20405147
BMC Psychiatry. 2011 Aug 23;11:140
pubmed: 21861908
J Scleroderma Relat Disord. 2017 Jan-Apr;2(1):11-18
pubmed: 28516167
Psychol Aging. 2017 Sep;32(6):507-520
pubmed: 28891665
Soc Sci Med. 1991;32(6):705-14
pubmed: 2035047
Semin Arthritis Rheum. 2022 Feb;52:151926
pubmed: 34785028
Am J Prev Med. 1994 Mar-Apr;10(2):77-84
pubmed: 8037935
Qual Life Res. 2017 Jan;26(1):85-94
pubmed: 27469505
Qual Life Res. 2019 Dec;28(12):3347-3354
pubmed: 31482431
Ann Behav Med. 2002 Winter;24(1):49-58
pubmed: 12008794
J Psychosom Res. 2012 Mar;72(3):199-204
pubmed: 22325699
Clin Exp Rheumatol. 2011 Mar-Apr;29(2 Suppl 65):S60-5
pubmed: 21586220
Lancet. 2017 Oct 7;390(10103):1685-1699
pubmed: 28413064